EGFR and oral cavity squamous cell carcinoma: In light of the observation that the functional inhibition of EGFR by AG1478, PTHrP silencing by RNA interference (RNAi), and combined application of these reagents exerted a prominent anti-tumoral effect, these findings raise the possibility to utilize both PTHrP and EGFR as therapeutic targets in oral squamous cell carcinoma.